Engineered AAVs can be used to specifically induce necroptosis of tumor cells in vitro. Engineered AAVs can be used to specifically induce necroptosis.

Slides:



Advertisements
Similar presentations
Identification of combination treatment–responsive effector/memory tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.
Advertisements

MP cells are generated from naïve cells in the periphery.
Impaired development of Treg cell function upon overexpression of FOXP3A384T in naïve CD4+CD25− T cells. Impaired development of Treg cell function upon.
Basic design concept of human mimetic humanoid.
Three different types of transfer functions with a codomain of [0,1].
Tfr cells’ transcriptomic profile distinguishes them from Treg and Tfh cells. Tfr cells’ transcriptomic profile distinguishes them from Treg and Tfh cells.
Improvement in the transcriptional activity of FOXP3A384T by enhancement of TIP60-FOXP3 interaction. Improvement in the transcriptional activity of FOXP3A384T.
Human PBMC-derived MERS-CoV–specific T cells are multifunctional.
Human cells produce type I and III IFNs upon Af stimulation.
Comparison of repertoire distributions to baseline.
A novice user executing various subtasks from study 1.
A shared-control method for effective bimanual robot manipulation.
Tukey boxplots overlaid on data points from objective and subjective measures, displaying results from study 1. Tukey boxplots overlaid on data points.
DC subset cooperation for activation of antiviral T cells.
Donor and recipient BAL T cells are phenotypically and functionally memory T cells. Donor and recipient BAL T cells are phenotypically and functionally.
Macrophage-resident NRP1 mitigates cytokine release and proinflammatory polarization. Macrophage-resident NRP1 mitigates cytokine release and proinflammatory.
Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells. Neutrophil recruitment to the colonic lamina propria depends on CD4+ T cells.
Fig. 5 Correlation of RNA expression and protein abundance.
Online verification using reachable occupancies.
Administration of necroptosis-targeting AAVs in conjunction within vivo promotes durable tumor clearance. Administration of necroptosis-targeting AAVs.
Immune-mediated tumor control by necroptotic cells requires NF-κB activation within dying cells but not MLKL-mediated cell lysis and DAMP release. Immune-mediated.
Fig. 2 Global production, use, and fate of polymer resins, synthetic fibers, and additives (1950 to 2015; in million metric tons). Global production, use,
Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. (A)
Taxonomic representation and metabolic potential in metagenomes
A summary of different energy sources for robotics.
Fig. 3 Conditionally expressed CAR using Notch as a signal induction and response pathway system. Conditionally expressed CAR using Notch as a signal induction.
Translation of a spherical object.
Fig. 3 Electron PSD in various regions.
Fig. 4 Resynthesized complex boronic acid derivatives based on different scaffolds on a millimole scale and corresponding yields. Resynthesized complex.
Fig. 1 meR marks on E2F1 confer genome-wide effects.
Slc7a5 expression in preosteoclasts is reduced in ovariectomized mice.
CD4+CLA+CD103+ T cells constitute a unique cell population in human blood. CD4+CLA+CD103+ T cells constitute a unique cell population in human blood. (A)
Fig. 1 Mean and median RCR (Relative Citation Ratio) of Roadmap Epigenomics Program research articles for each year. Mean and median RCR (Relative Citation.
NK cell immune evasion occurs through loss of TNF pathway members.
Slc7a5 deficiency stimulates osteoclastogenesis in vitro.
Fig. 1 Engineered expression of PSMA variants on CD19 CAR T cells.
Fig. 2 CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo. CD19 CAR T cells expressing tPSMA maintain function in vitro and in vivo.
m6A identification method based on m6A sensitive RNA endoribonuclease
Fig. 1 Product lifetime distributions for the eight industrial use sectors plotted as log-normal probability distribution functions (PDF). Product lifetime.
Ado loss drives TNF-dependent immune evasion.
Memory-biased TCRs induce weaker TCR signals than effector-biased TCRs in vitro. Memory-biased TCRs induce weaker TCR signals than effector-biased TCRs.
Loss of BAP1 blocks T cell differentiation at the DN3 stage in vitro.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
Fig. 5 EGLN2-mediated HIF1A down-regulation promotes ferroptosis.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 1 Bioinspired design of AAD for promoting wound contraction.
Fig. 3 The rs risk enhancer is a hub for intrachromosomal and interchromosomal interactions. The rs risk enhancer is a hub for intrachromosomal.
In vitro cell-release experiments on a glass substrate.
Fig. 6 RUNX/CBFB interaction inhibitor, Ro5-3335, significantly decreases mouse neurofibroma growth in vivo. RUNX/CBFB interaction inhibitor, Ro5-3335,
AEGIS autonomous targeting process.
Partial alteration of the Treg gene signature by the p.A384T mutation.
Fig. 3 Production of protein and Fe(II) at the end of growth correlated with increasing concentrations of ferrihydrite in the media that contained 0.2.
Fig. 4 Dox-CBD-SA treatment shows reduced toxicity.
Fig. 4 Differential histone modifications at promoters in various brain cell populations. Differential histone modifications at promoters in various brain.
Treg expression of Gata3 plays a major role in controlling dermal fibrosis. Treg expression of Gata3 plays a major role in controlling dermal fibrosis.
Fig. 5 The regulatory and functional properties of RECs.
Tregs preferentially regulate TH2 cytokines in skin.
Fig. 1 Location of the Jirzankal Cemetery.
UNC drives MYC protein loss.
CAR expression promotes tonic activation of signaling networks.
Fig. 3 Effects of ASO and eGLP1-ASO conjugates on gene expression and protein levels in vitro in cell lines and primary mouse islet cells. Effects of ASO.
Fig. 1 Schematic depiction of a paradigm for rapid and guided discovery of materials through iterative combination of ML with HiTp experimentation. Schematic.
Acute circadian disruption alters ILC3 cytokine secretion.
Fig. 4 Behavior of resistance peak near density nm = 5.
Circadian gene expression in ILC3s is associated with rhythmic cytokine expression. Circadian gene expression in ILC3s is associated with rhythmic cytokine.
Fig. 1 ETL kills 4T1 breast carcinoma cells more efficiently than ST under static conditions. ETL kills 4T1 breast carcinoma cells more efficiently than.
Fig. 5 CD19-tPSMA(N9del) CAR T cell numbers in mouse and human.
Correlation of TAN phenotypes and TIL effector function.
Fig. 2 Astrocyte-specific AAV2/5 RiboTag.
Presentation transcript:

Engineered AAVs can be used to specifically induce necroptosis of tumor cells in vitro. Engineered AAVs can be used to specifically induce necroptosis of tumor cells in vitro. (A) Schematic of AAVs used to transduce tumor cells to express engineered pro-death enzymes fused to a constitutively oligomerizing (co) recruitment domain under the control of a synthetic MND promoter, leading to subsequent induction of a corresponding PCD modality. (B and C) Validation and kinetics of AAV2.5 serotype transduction efficiency in B16.F10 cells in vitro. (B) Percent of GFP+ cells transduced with AAV2.5-eGFP control. (C) Percent cell death in cells transduced with various death-inducing constructs. n = 3 technical replicates per group. (D) Heatmap depicting relative expression values of NF-κB–dependent gene targets, chemokines, and cytokines via NanoString analysis of B16.F10 tumor cells compared to eGFP-transduced controls 10 hours after AAV2.5 transduction (1 × 1011 IFU). Data are representative plots from two independent experiments (B and C) or means of three technical replicates from one experiment (D). Annelise G. Snyder et al. Sci. Immunol. 2019;4:eaaw2004 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works